Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Transfusion for Endothelial Protection in Liver Transplant
NCT04107883Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Randomised trial of fresh-frozen plasma in liver disease (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Endothelial glycocalyx layer shedding markers at 24 hours. Status: unknown.
02
Drugs
fresh-frozen plasma
03
Conditions
liver disease
Beyond the preview
Go deeper on NCT04107883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04107883.